Research Associate at the Early Cancer Institute
Dr Daniel Jacobson is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. He is now a Research Associate at the Early Cancer Institute at the University of Cambridge, studying the evolution of gastric and oesophageal cancer. Previously, he completed his PhD in computational cancer genetics at University College London (UCL), as part of the UCL-Birkbeck MRC Doctoral Training Partnership, where he was using machine learning and cancer genomics data to study drug sensitivity and resistance in breast cancer. He previously obtained an MSci in Natural Sciences, also at UCL, and is a keen science writer and communicator, as well as a culture writer. He tweets as @DanH_Jacobson
A patient with type 1 diabetes has been successfully treated with donor pancreas cells modified to evade the immune system...
Nearly 500 'switch-like' genes that are either expressed highly or not at all have been identified from a large-scale study of gene expression from almost one thousand people...
A novel gene therapy may improve the trajectories of patients with Duchenne muscular dystrophy, according to early trial results...
An at-home spit test to identify patients at risk of prostate cancer, using a polygenic risk score, has been shown to outperform current testing methods...
A child who was treated in utero for spinal muscular atrophy is showing no signs of the condition over two years later...
Dr Dan Jacobson concludes Lawrence Ingrassia's book is: 'an expansive, masterful piece of science communication, which doubles beautifully as memoir and biography of modern oncology'...
Circular DNA existing outside chromosomes can drive cancer growth and is a potential drug target, according to three papers published this week in Nature...
Genome editing using small protein structures has the potential to be more efficient, with increased specificity, than current methods – such as CRISPR/Cas genome editing...
A machine learning tool has inferred risk factors associated with over one thousand diseases, offering the possibility for improving early disease detection and drug discovery...
Adverse effects from immunotherapy treatment in melanoma patients are associated with a distinct pattern of gene expression, offering the possibility for improved therapeutic strategies...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
